GeoVax Labs GOVX
NASDAQ GOVX
$0.35 +0.01 (+1.82%)
At close: Sep 29, 2026 · 4:00 PM EDT

GeoVax Labs (GOVX) Receivables (2024 - 2025)

Updated

GeoVax Labs (GOVX) posted Receivables of $532,771 for Q2 2025, up 77.2% from $300,677 a year earlier but down 64.4% from the prior quarter.

Analysis

GeoVax Labs (GOVX) Receivables (2024 - 2025) Analysis & Trends

At the end of FY2024, GeoVax Labs' Receivables came in at $659,409.

  • Quarterly Receivables has run from a low of $300,677 in Q2 2024 to a high of $1.5 million in Q1 2025 over five years.
  • According to Business Quant data, Receivables for the three prior quarters was $1.5 million (Q1 2025), $659,409 (Q4 2024) and $547,574 (Q3 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 GeoVax Labs 1.60 Mn -12.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 532,771.00
Mar 31, 2025 1.50 Mn
Dec 31, 2024 659,409.00
Sep 30, 2024 547,574.00
Jun 30, 2024 300,677.00
API Access

GeoVax Labs Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=GOVX&period=max&api_key=YOUR_API_KEY